(Reuters) - AstraZeneca Plc (L:AZN) said on Saturday that its COVID-19 vaccine trial in the United States is still on hold.
AstraZeneca on Saturday published a document https:// describing details of how the COVID-19 vaccine trial was being carried out, which was first reported by the New York Times.